載入...
Population Pharmacokinetic and Pharmacodynamic Analysis To Evaluate a Switch to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in People Living with HIV-1
Doravirine is a non-nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus type 1 (HIV-1) infection. A population pharmacokinetic (PK) model for treatment-naive participants in doravirine clinical studies was updated with data from switch participants in the DRIVE-S...
Na minha lista:
| 發表在: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7577165/ https://ncbi.nlm.nih.gov/pubmed/32868326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00590-20 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|